Pfizer DCB30 (Vizimpro 30 mg)
Generic Name: dacomitinib
Pill with imprint Pfizer DCB30 is Blue, Round and has been identified as Vizimpro 30 mg. It is supplied by Pfizer Inc.
Vizimpro is used in the treatment of non-small cell lung cancer and belongs to the drug classes EGFR inhibitors, HER2 inhibitors. Vizimpro 30 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer DCB30
Vizimpro
- Generic Name
- dacomitinib
- Imprint
- Pfizer DCB30
- Strength
- 30 mg
- Color
- Blue
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- EGFR inhibitors, HER2 inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-1198
More about Vizimpro (dacomitinib)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Drug images
- Pricing & coupons
- En español
- Drug class: EGFR inhibitors
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.